Trials / Completed
CompletedNCT03353636
Bioavailability of Magnesium Supplements
A Randomized, Double-blind, Placebo-controlled, Crossover Trial to Compare the Bioavailability of Magnesium From Magnesium Carbonate Powder With Three Marketed Magnesium Supplements
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Natural Calm Canada · Industry
- Sex
- Female
- Age
- 35 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this clinical trial is to demonstrate the superiority of Natural Calm magnesium powder with respect to absorption when compared to three marketed forms of magnesium (two magnesium bisglycinate powders and magnesium citrate capsules). The primary endpoints were serum magnesium AUC (0-8h) and urine magnesium AUC (0-8h) after a single dose of 150 mg elemental magnesium.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Magnesium | 150mg elemental magnesium |
| DIETARY_SUPPLEMENT | Placebo | Rice flour |
Timeline
- Start date
- 2016-06-27
- Primary completion
- 2017-02-03
- Completion
- 2017-02-06
- First posted
- 2017-11-27
- Last updated
- 2017-11-29
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03353636. Inclusion in this directory is not an endorsement.